About LymeAlarm

Dedicated to ending preventable Lyme disease suffering through technology

Our Mission

LymeAlarm was founded on a straightforward but urgent premise: Lyme disease is largely preventable, yet hundreds of thousands of Americans are diagnosed every year — many after months of misdiagnosis and suffering. We exist to change that.

Our platform uses a combination of environmental surveillance, biosensor data integration, AI-powered pattern recognition, and real-time alerting to help individuals, healthcare providers, and public health agencies stay ahead of Lyme disease. By detecting risk early — before symptoms appear — we can dramatically improve treatment outcomes and reduce the chronic disease burden that affects so many patients.

We are a mission-driven company that believes healthcare technology should be proactive, not reactive. With the support of our investors and healthcare partners, we are building a future where tick-borne illness is no longer a silent epidemic.

Our Approach

LymeAlarm's technology stack combines several cutting-edge disciplines:

  • Environmental Intelligence: We aggregate tick activity data from wildlife agencies, citizen science platforms, and IoT sensor networks to build the most comprehensive tick surveillance database in the country.
  • Biosensor Integration: Our platform connects with wearable health devices to monitor temperature trends, heart rate variability, sleep disruption, and other biosignals that correlate with early-stage Lyme disease infection.
  • Machine Learning: Our algorithms continuously learn from anonymized population health data to improve detection accuracy and personalize risk assessments.
  • Clinical Partnerships: We work directly with infectious disease specialists and primary care physicians to validate our alert protocols and ensure clinical relevance.

2022

Year Founded

50K+

Users Protected

200+

Healthcare Partners

97%

Detection Accuracy

Recent Funding

LymeAlarm raised a $2.8M Seed Round in May 2025, led by Fortify Fund. This investment will accelerate platform development, expand our healthcare partnerships, and grow our geographic coverage to protect more communities.

Read the announcement →

Company Timeline

2022 — Founded

LymeAlarm is founded in San Francisco by Erin Dawicki and Dr. James Park after witnessing firsthand the devastating impact of late-stage Lyme disease on patients and families.

2023 — Platform Launch

Beta version of LymeAlarm platform launches with geographic risk mapping and basic alert features. First 5,000 users onboarded across the Northeast US.

2024 — Wearable Integration

LymeAlarm integrates with major wearable health devices, enabling biosensor-based early detection. Healthcare provider dashboard launched with HIPAA compliance certification.

May 2025 — Seed Funding

Raised $2.8M Seed Round led by Fortify Fund to expand coverage, improve AI detection algorithms, and grow our clinical partnership network nationwide.